270 related articles for article (PubMed ID: 38318098)
1. MDMX in Cancer: A Partner of p53 and a p53-Independent Effector.
Lin W; Yan Y; Huang Q; Zheng D
Biologics; 2024; 18():61-78. PubMed ID: 38318098
[TBL] [Abstract][Full Text] [Related]
2. Regulation of p53: a collaboration between Mdm2 and Mdmx.
Pei D; Zhang Y; Zheng J
Oncotarget; 2012 Mar; 3(3):228-35. PubMed ID: 22410433
[TBL] [Abstract][Full Text] [Related]
3. Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Qi SM; Cheng G; Cheng XD; Xu Z; Xu B; Zhang WD; Qin JJ
Front Cell Dev Biol; 2020; 8():233. PubMed ID: 32300595
[TBL] [Abstract][Full Text] [Related]
4. Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges.
Yu DH; Xu ZY; Mo S; Yuan L; Cheng XD; Qin JJ
Front Oncol; 2020; 10():1389. PubMed ID: 32850448
[TBL] [Abstract][Full Text] [Related]
5. Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.
Zhang Y; Zeng SX; Hao Q; Lu H
Dev Biol; 2017 Mar; 423(1):34-45. PubMed ID: 28118981
[TBL] [Abstract][Full Text] [Related]
6. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.
Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT
Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179
[TBL] [Abstract][Full Text] [Related]
7. MDMX under stress: the MDMX-MDM2 complex as stress signals hub.
de Polo A; Vivekanandan V; Little JB; Yuan ZM
Transl Cancer Res; 2016 Dec; 5(6):725-732. PubMed ID: 30319942
[TBL] [Abstract][Full Text] [Related]
8. Protecting the genome from mdm2 and mdmx.
Melo AN; Eischen CM
Genes Cancer; 2012 Mar; 3(3-4):283-90. PubMed ID: 23150761
[TBL] [Abstract][Full Text] [Related]
9. The past, present and future of potential small-molecule drugs targeting p53-MDM2/MDMX for cancer therapy.
Liu Y; Wang X; Wang G; Yang Y; Yuan Y; Ouyang L
Eur J Med Chem; 2019 Aug; 176():92-104. PubMed ID: 31100649
[TBL] [Abstract][Full Text] [Related]
10. Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.
Hernández-Monge J; Rousset-Roman AB; Medina-Medina I; Olivares-Illana V
Genes Cancer; 2016 Sep; 7(9-10):278-287. PubMed ID: 28050229
[TBL] [Abstract][Full Text] [Related]
11. An Update on MDMX and Dual MDM2/X Inhibitors.
Espadinha M; Barcherini V; Lopes EA; Santos MMM
Curr Top Med Chem; 2018; 18(8):647-660. PubMed ID: 29866007
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX.
Phan J; Li Z; Kasprzak A; Li B; Sebti S; Guida W; Schönbrunn E; Chen J
J Biol Chem; 2010 Jan; 285(3):2174-83. PubMed ID: 19910468
[TBL] [Abstract][Full Text] [Related]
13. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE.
Gerarduzzi C; de Polo A; Liu XS; El Kharbili M; Little JB; Yuan ZM
J Biol Chem; 2016 Dec; 291(50):25937-25949. PubMed ID: 27777309
[TBL] [Abstract][Full Text] [Related]
15. MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan M; Lopez-Pajares V; Yuan ZM
Transl Cancer Res; 2012 Aug; 1(2):88-89. PubMed ID: 23002429
[TBL] [Abstract][Full Text] [Related]
16. MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice.
Matijasevic Z; Steinman HA; Hoover K; Jones SN
Mol Cell Biol; 2008 Feb; 28(4):1265-73. PubMed ID: 18039860
[TBL] [Abstract][Full Text] [Related]
17. The role of miRNAs in MDMX-p53 interplay.
Yu D; Xu Z; Cheng X; Qin J
J Evid Based Med; 2021 May; 14(2):152-160. PubMed ID: 33988919
[TBL] [Abstract][Full Text] [Related]
18. Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present).
Zak K; Pecak A; Rys B; Wladyka B; Dömling A; Weber L; Holak TA; Dubin G
Expert Opin Ther Pat; 2013 Apr; 23(4):425-48. PubMed ID: 23374098
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
Lemos A; Leão M; Soares J; Palmeira A; Pinto M; Saraiva L; Sousa ME
Med Res Rev; 2016 Sep; 36(5):789-844. PubMed ID: 27302609
[TBL] [Abstract][Full Text] [Related]
20. The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells.
Matijasevic Z; Krzywicka-Racka A; Sluder G; Gallant J; Jones SN
Oncogenesis; 2016 Oct; 5(10):e262. PubMed ID: 27694836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
